Table 2.
Cost per case
|
|||
---|---|---|---|
1% increase: | 5% increase: | 10% increase: | |
Mean | $177.13 (±75.43) | $35.43 (±15.08) | $17.71 (±7.54) |
Range | $7.33–$881.02 | $1.47–$176.20 | $0.73–$88.10 |
% under $10 | 4 | 24 | 48 |
% under $50 | 24 | 72 | 96 |
% under $100 | 48 | 96 | 100 |
% under $200 | 72 | 100 | 100 |
Sources: BRFSS 2012; ACS 2012; CAT 2009–2912.
Notes:
For example, if there was a 1% increase in screening rates, 72% of the grantees would incur cost of less than $200 per person while only 4% of grantees would incur cost less than $10 per person screened.
The purpose of the CRCCP is to promote colorectal cancer (CRC) screening to increase population-level screening rates and, subsequently, to reduce CRC incidence and mortality.
In 2012 the national screening rate was 65.5% (65.1–65.9), and the grantee screening rate was 67.5% (66.9–68.1) (BRFSS 2012).